Dopamine Gene Therapy for Parkinson’s Disease in a Nonhuman Primate Without Associated Dyskinesia
- 14 October 2009
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 1 (2) , 2ra4
Abstract
A gene therapy approach for the treatment of Parkinson’s disease.Keywords
This publication has 54 references indexed in Scilit:
- Striatal Plasticity and Basal Ganglia Circuit FunctionNeuron, 2008
- L-dopa dose and the duration and severity of dyskinesia in primed MPTP-treated primatesJournal of Neural Transmission, 2007
- Coexpression of Tyrosine Hydroxylase, GTP Cyclohydrolase I, Aromatic Amino Acid Decarboxylase, and Vesicular Monoamine Transporter 2 from a Helper Virus-Free Herpes Simplex Virus Type 1 Vector Supports High-Level, Long-Term Biochemical and Behavioral Correction of a Rat Model of Parkinson's DiseaseHuman Gene Therapy, 2004
- New Methods to Titrate EIAV-Based Lentiviral VectorsMolecular Therapy, 2002
- Behavioral Recovery in a Primate Model of Parkinson's Disease by Triple Transduction of Striatal Cells with Adeno-Associated Viral Vectors Expressing Dopamine-Synthesizing EnzymesHuman Gene Therapy, 2002
- Anatomic and Biochemical Correlates of the Dopamine Transporter Ligand 11C-PE2I in Normal and Parkinsonian Primates: Comparison with 6-[18F]Fluoro-L-DopaJournal of Cerebral Blood Flow & Metabolism, 2001
- Triple Transduction with Adeno-Associated Virus Vectors Expressing Tyrosine Hydroxylase, Aromatic-L-Amino-Acid Decarboxylase, and GTP Cyclohydrolase I for Gene Therapy of Parkinson's DiseaseHuman Gene Therapy, 2000
- Transient Acute Depression Induced by High-Frequency Deep-Brain StimulationNew England Journal of Medicine, 1999
- Changes in local cerebral glucose utilization associated with Parkinson's syndrome induced by 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) in the primateLife Sciences, 1987
- ParkinsonismNeurology, 1967